Personal profile
Biography
Dr Tatiana (Tanya) Soboleva received her undergraduate training in biochemistry at the Moscow State University. In 1998 she was awarded an International Postgraduate Research Scholarship by the Australian Government. She undertook her PhD study at the JCSMR, ANU, with Dr. Rohan Baker and was awarded a PhD in Molecular Medicine for her work investigating nucleocytoplasmic transport of the de-ubiquitilating enzyme, Usp4. In 2003 she undertook post-doctoral studies with Prof. Ian Young (JCSMR, ANU), investigating how the cytokines activate their receptor systems. In 2006 she joined Prof. David Tremethick’s laboratory (JCSMR, ANU). Together with Prof. Tremethick, she discovered a novel histone variant, which is involved in the activation of genes expressed during specific stages of spermatogenesis. Since 2012, Dr Soboleva established a subgroup in Prof. Tremethick's laboratory and an independent group in 2019. Our collaborative work is based on undertsadning of functions of spermatogenesis-specific epigenetic factors as well as their role when they become upregulated in various cancers.
Qualifications
PhD in Molecular Medicine
Research Interests
Our group is interested in research that connects epigenetics, cell differentiation and cancer. Epigenetic mechanisms control our genome and ensure that every cell expresses a certain set of genes that defines its cell type specificity. Epigenetic control of the genome has to be dynamic and rigid at the same time, to ensure that the cell maintains its function but can adapt to developmental or environmental changes. The flaws in these finely tuned epigenetic mechanisms can be very detrimental and lead to disease states including cancer.
Our research is focused on study of epigenetic control of normal developmental processes, using spermatogenesis (the development and differentiation of male germ cells) as an excellent differentiation model system. On the other hand, we study how epigenetic deregulation is involved in cancer development, examining germ-cell specific epigenetic regulators, that are aberrantly overexpressed in cancer.
Majority of our research is focused around an epigenetic regulator that was discovered in our laboratory, the histone variant H2A.B, that is testis and brain-specific. This histone variant is targeted to the transcription start sites (TSSs) to co-ordinately activates transcription by a chromatin ‘opening’ mechanism. More recently, we showed that H2A.B can directly bind RNA and is involved in pre-mRNA splicing. This was a major paradigm shift because it showed for the first time that a histone could not only interact directly with DNA but also with RNA. To study H2A.B function, we generated a H2A.B KO mouse model and showed that downregulation of H2A.B affects male fertility and brain function. The unique ability of H2A.B histone to interact with DNA and RNA as well as the RNA processing machinery, opens up a whole new field of research that will provide new insights into the epigenetic regulation.
The Cancer and Germ Cell Epigenetics Group closely collaborates with The Chromatin and Translational Regulation group, led by Prof Tremethick. We have a number of current and potential projects that aim to uncover previously unreported mechanisms of epigenetic control coordinated by H2A.B. See JCSMR student projects for details.
Research student supervision
- Registered to supervise
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
An Improved Method for Purification of the Residual Bodies from the Seminiferous Tubules of Mice
Apu, M. N. H., Shirokikh, N. E., Khochbin, S. & Soboleva, T. A., 7 Nov 2023, In: Current Protocols. 3, 11, 15 p., e920.Research output: Contribution to journal › Article › peer-review
Open Access -
H2A.B is a cancer/testis factor involved in the activation of ribosome biogenesis in Hodgkin lymphoma
Jiang, X., Wen, J., Paver, E., Wu, Y. H., Sun, G., Bullman, A., Dahlstrom, J., Tremethick, D. J. & Soboleva, T. A., 4 Aug 2021, In: EMBO Reports. 22, 8, e52462.Research output: Contribution to journal › Article › peer-review
Open Access9 Citations (Scopus) -
Short Histone H2A Variants: Small in Stature but not in Function
Jiang, X., Soboleva, T. A. & Tremethick, D. J., 2 Apr 2020, In: Cells. 9, 4, 408.Research output: Contribution to journal › Review article › peer-review
Open Access25 Citations (Scopus) -
Gene editing of the multi-copy H2A.B gene and its importance for fertility
Anuar, N. D., Kurscheid, S., Field, M., Zhang, L., Rebar, E., Gregory, P., Buchou, T., Bowles, J., Koopman, P., Tremethick, D. J. & Soboleva, T. A., 31 Jan 2019, In: Genome Biology. 20, 1, 23.Research output: Contribution to journal › Article › peer-review
Open Access33 Citations (Scopus) -
RChIP-Seq: Chromatin-Associated RNA Sequencing in Developmentally Staged Mouse Testes
Soboleva, T. A. & Tremethick, D. J., 2018, Methods in Molecular Biology. Humana Press Inc., p. 169-184 16 p. (Methods in Molecular Biology; vol. 1832).Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
1 Citation (Scopus)
-
Targeting a novel epigenetic regulator of Hodgkin lymphoma, H2A.B, for treament of cancer
Soboleva, T. (PI) & Sobolev, A. S. (CoI)
1/01/22 → 31/12/26
Project: Research
-
Communication via epigenetic mechanisms: cell cross-talk and male fertility
Soboleva, T. (PI) & Khochbin, S. (CoI)
1/01/22 → 31/12/26
Project: Research
-
NHMRC Equipment Grant 2021: ACDT Equipment - Linked to ARIES ID 39296
Hannan, R. (PI), Burgio, G. (CoI), Dehorter, N. (CoI), Fischer, T. (CoI), Gardiner, E. (CoI), George, A. (CoI), McMorran, B. (CoI), Palmer, S. (CoI), Schulte, K.-M. (CoI), Shirokikh, N. (CoI) & Soboleva, T. (CoI)
6/10/21 → 31/12/21
Project: Research
-
Epigenetic regulator H2A.B as a novel target for treatment of Hodgkin Lymphoma
Soboleva, T. (PI), George, A. (CoI) & Hart-Smith, G. (CoI)
1/06/21 → 15/12/22
Project: Research
-
Uncovering new epigenetic-based regulatory mechanisms of gene expression: novel links between histone variants, RNA function and disease
Tremethick, D. (PI) & Soboleva, T. (CoI)
1/01/18 → 31/12/22
Project: Research